Stay updated on STX209 Effects in ASD Clinical Trial
Sign up to get notified when there's something new on the STX209 Effects in ASD Clinical Trial page.
Latest updates to the STX209 Effects in ASD Clinical Trial page
- CheckyesterdayChange DetectedUI updates include adding Show glossary and Hide glossary controls, and minor label adjustments such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The page revision was bumped to v3.4.0.SummaryDifference0.3%
- Check9 days agoChange DetectedRevision: v3.3.4 replaces the previous Revision: v3.3.3 in the page footer; no impact on study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedAdded a Locations section highlighting Pennsylvania. Updated the revision to v3.3.3 and removed the HHS Vulnerability Disclosure and Pennsylvania Locations entry (v3.3.2).SummaryDifference0.2%
- Check59 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check66 days agoChange DetectedRemoval of the government funding status and data currency disclaimer from the page. This may affect how clearly users understand whether the trial information is current.SummaryDifference0.4%
- Check88 days agoChange DetectedNo additions or deletions affecting core content were detected. The page's study details, eligibility criteria, and primary outcomes appear unchanged.SummaryDifference0.4%
Stay in the know with updates to STX209 Effects in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STX209 Effects in ASD Clinical Trial page.